Tim Carmichael (@TimCarmichael3) profile picture

Living the dream. No free lunch on Wall Street.

Monmouth Beach, NJ/Jupiter,FL
Joined October 2012
Photo by Tim Carmichael (@TimCarmichael3)Photo by Tim Carmichael (@TimCarmichael3)Photo by Tim Carmichael (@TimCarmichael3)Photo by Tim Carmichael (@TimCarmichael3)
The meeting is nothing more than a photo to disguise the problems they are all having at home. There’s nothing wrong with leaders meeting for coffee but everyone knows there is nothing of substance coming out of this. Trump believes the. meet & greet is “substantive” but that’s ok —- as he avoids licking the biggest loss since Watergate for Republicans (!) for his absolutely inane “decision making “. Nice having him out of the country— he doesn’t have to be around for his Administration to screw up on a daily basis.
No meeting Trump has ever had with Putin has ever solved a problem. Hoping this upcoming one will be different.
1
142
$TGTX double top breakout — this is what you see when the shares are being controlled by investors with strong hands. What could the short sellers possibly be thinking??!!🚀🚀🚀🚀
$TGTX News Coming? Shorts covering? Why so much strength in these crappy market conditions?
3
1
22
991
$AZN - AstraZeneca Receives Two U.S. FDA Approvals, Including Expanded Use of Imfinzi and a New Treatment for a Rare Disease
147
Tim Carmichael retweeted
Less than a year ago, DOGE cut 400 jobs at the already understaffed FAA. At the time, FAA employees said the cuts would "have long-term safety implications." Looks like they were right. apnews.com/article/faa-firin…
807
4,226
194
11,303
209,339
$TGTX next meaningful stock trigger —- BRIUMVI SubQ data readout —- is just around the corner. This data could lead to higher revenue targets and blast the 30 million shares SOLD SHORT into covering their $$ losing negative bets🚀🚀🚀
$TGTX OW -JP catch up MGT -comments on next meaningful leg of BRIUMVI story -SUBq on track readout YE/early next year - trial has passed time points to collect 6 month PK endpoint for all 360 patients - data cleaning underway
1
1
15
668
$QURE high risk/ high reward — nothing available to patients with the deadly Huntingtons Disease. Risk/reward could be very positive over the next 6 months💥💥💥
Mr. Diamantas, the FDA Commissioner, literally telling you the vibes at the FDA. If you don't think $QURE isn't getting approved you've lost the plot.
5
824
$TGTX new 52 week high — 30 million shares SOLD SHORT. Must be getting a little hot under the collar betting that the strong fundamentals & technicals are going away🔥🔥🔥🔥🔥
1
21
652
$TGTX Jeffries like the story — PT $83
$TGTX Jefferies PT $83 SUBq on track &Commercial trends remain strong, w/ new pt starts accelerating exiting 3Q &into 4Q, Oct marking a record month for total Briumvi prescribers, and persistence remaining above Co's expectations. Tx-naive pts now represent ~40% of new pt starts vs. ~25% at launch, while ~1/3 of starts come from pts switching from another CD20. Co also highlighted increasing adoption among younger women aged 18-40, likely driven by increase in new starts. Hospital penetration is improving, w/ Sept and Oct representing strongest hospital months since launch.
13
395
$TGTX Having been invested in $TGTX for the last 5 years I’ve seen how people get too anxious around Q earnings announcements. Having such a large short position —all with $ losing positions— and jittery retail traders looking for takeovers will do that. The shorts did their best to drill the stock down to the low $50s and failed — as institutional investors added to positions cleaning out the shaky sellers. $TGTX continues to be in an enviable position, raising revenue and earnings estimates — as they continue to take market share Q after Q. The story remains very much on track and looks to be a favorable risk/reward from current levels. Look for new highs. 💥💥💥💥
1
23
821